Overview

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This research is being done to study how the immune system in the small intestine improves after taking antiretroviral (anti-HIV) medications. The main purpose is to measure the increase in the numbers of immune cells in the intestine to see if one type of HIV medication gives different results than other types of HIV medications.
Phase:
N/A
Details
Lead Sponsor:
University of California, Davis
Treatments:
Efavirenz
Raltegravir Potassium
Reverse Transcriptase Inhibitors